Literature DB >> 7497166

Gene-targeted mice in leukocyte adhesion research.

K Ley1.   

Abstract

Physiologic and inflammatory leukocyte trafficking are controlled by adhesion molecules on leukocytes and endothelial cells. These adhesion molecules can be grouped into four major families: integrins, immunoglobulinlike molecules, selectins, and glycoproteins serving as selectin ligands. The recent advent of gene-targeting technology in embryonal stem cells has prompted the production of mutant mice that lack individual adhesion molecules or combinations thereof. Such gene-targeted mice permit studies into the roles of adhesion molecules in acute and chronic inflammation and of the regulation and interplay between different sets of adhesion receptors in vivo. Microcirculatory studies have been indispensable to our understanding of the importance of certain adhesion molecules for different steps of leukocyte recruitment in vivo. Targeting new genes and investigating mice with combined adhesion-molecule deficiencies will help to further clarify the molecular mechanisms of leukocyte trafficking in health and disease. This article reviews the insight gained through using adhesion molecule-deficient mice, emphasizing the role of microcirculatory studies in this research.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7497166     DOI: 10.3109/10739689509146762

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  7 in total

1.  Identification of nucleolin as a new L-selectin ligand.

Authors:  G Harms; R Kraft; G Grelle; B Volz; J Dernedde; R Tauber
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

2.  Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice.

Authors:  D K Kaul; R P Hebbel
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.

Authors:  H A Lehr; A S Weyrich; R K Saetzler; A Jurek; K E Arfors; G A Zimmerman; S M Prescott; T M McIntyre
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

4.  HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosis.

Authors:  Nicole C Smits; Takashi Kobayashi; Pratyaksh K Srivastava; Sladjana Skopelja; Julianne A Ivy; Dustin J Elwood; Radu V Stan; Gregory J Tsongalis; Frank W Sellke; Peter L Gross; Michael D Cole; James T DeVries; Aaron V Kaplan; John F Robb; Scott M Williams; Nicholas W Shworak
Journal:  Matrix Biol       Date:  2017-01-23       Impact factor: 11.583

5.  Identification of human complement Factor H as a ligand for L-selectin.

Authors:  R Malhotra; M Ward; R B Sim; M I Bird
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

6.  Experimental models to study microcirculatory dysfunction in muscle ischemia-reperfusion and osteomyocutaneous flap transfer.

Authors:  Michael D Menger; Matthias W Laschke; Michaela Amon; Rene Schramm; Henrik Thorlacius; Martin Rücker; Brigitte Vollmar
Journal:  Langenbecks Arch Surg       Date:  2003-10-07       Impact factor: 3.445

7.  Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.

Authors:  Shahrokh Falati; Qingde Liu; Peter Gross; Glenn Merrill-Skoloff; Janet Chou; Erik Vandendries; Alessandro Celi; Kevin Croce; Barbara C Furie; Bruce Furie
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.